Showing results (1871-1880 of 2,306) with videos related to
Sort By:
Pageof 231
International Journal of Particle Therapy|July 21, 2021
Clinical Outcomes Following Dose-Escalated Proton Therapy for Skull-Base ChordomaAdam L Holtzman, Ronny L Rotondo, Michael S Rutenberg, et al.Journal of Neurophysiology|October 26, 2018
Development of human electrophysiological brain networksPaul M Briley, Elizabeth B Liddle, Madeleine J Groom, et al.International Journal of Particle Therapy|January 21, 2026
Long-Term Outcomes of Consolidative Proton Therapy for Pediatric Classical Hodgkin LymphomaDaniela Martir-Vargas, Daniel J Indelicato, Allison Bechtel, et al.Surgery|November 19, 2013
Observation of clinically negative central compartment lymph nodes in papillary thyroid carcinomaIain J Nixon, Ian Ganly, Snehal G Patel, et al.Journal of the American Chemical Society|December 21, 2013
Ammonia-rich high-temperature superconducting intercalates of iron selenide revealed through time-resolved in situ X-ray and neutron diffractionStefan J Sedlmaier, Simon J Cassidy, Richard G Morris, et al.The Journal of Physical Chemistry. B|September 21, 2017
Ab Initio QM/MM Modeling of the Rate-Limiting Proton Transfer Step in the Deamination of Tryptamine by Aromatic Amine DehydrogenaseKara E Ranaghan, William G Morris, Laura Masgrau, et al.The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndromeAndrea M Isidori, Gregory A Kaltsas, Shahid Mohammed, et al.Neurology|May 10, 2000
Significance of interictal bilateral temporal hypometabolism in temporal lobe epilepsyM Koutroumanidis, M J Hennessy, P T Seed, et al.Neurology|January 3, 2001
N-Acetylaspartate and creatine levels measured by (1)H MRS relate to recognition memoryC H Ferrier, G Alarcón, A Glover, et al.Irish Journal of Medical Science|June 28, 2018
Absence of thyroid transcription factor-1 expression is associated with poor survival in patients with advanced pulmonary adenocarcinoma treated with pemetrexed-based chemotherapyMark K Doherty, Emer O'Connor, David Hannon, et al.Pageof 231